Editor-in-Chief

Michael T. Lotze, MD
University of Pittsburgh – United States

Deputy Editor-in-Chief

Sjoerd H. van der Burg, PhD
Oncode Institute & Leiden University Medical Center – Netherlands

Basic and Translational Cancer Immunology Section

Section Editors

Claudia Palena, PhD
National Cancer Institute, National Institutes of Health – United States

Walter J. Storkus, PhD
University of Pittsburgh – United States

Eric Tartour, MD, PhD
Hôpital Européen Georges Pompidou – France

Deputy Editor

Hongbo Hu, PhD
West China Hospital, Sichuan University – China

Associate Editors

Scott I. Abrams, PhD
Roswell Park Comprehensive Cancer Center – United States

Timothy NJ Bullock, PhD
University of Virginia – United States

Gennaro Ciliberto, MD
IRCCS Istituto Nazionale Tumori Regina Elena – Italy

Tanja D. de Gruijl, PhD
Amsterdam University Medical Centers – Netherlands

Jennifer L. Guerriero, PhD
Brigham and Women’s Hospital – United States

Pawel Kalinski, MD, PhD
Roswell Park Comprehensive Cancer Center – United States

Khashayarsha Khazaie, PhD, DSc
Mayo Clinic College of Medicine – United States

Sattva S. Neelapu, MD
The University of Texas MD Anderson Cancer Center United States

Anna Obenauf, PhD
Research Institute of Molecular Pathology Austria

Michael Platten, MD
Ruprecht-Karls University Heidelberg – Germany

Gabriel Rabinovich, PhD
Instituto de Biologia y Medicina Experimental (IByME) – Argentina

Alessandro Russo, MD, PhD
Università degli Studi di Messina – Italy

Stefani Spranger, PhD
Massachusetts Institute of Technology – United States 

Viktor Umansky, MD, PhD
German Cancer Research Center (DKFZ) – Germany

Louis M. Weiner, MD
Georgetown University Lombardi Cancer Center – United States

Case Reports Section

Section Editor

Sebastian Kobold, MD
Klinikum der Universität München – Germany

Associate Editors

Jack D. Bui, MD, PhD
University of California San Diego – United States

Marco Donia, MD, PhD
National Center for Cancer Immune Therapy (CCIT-DK) – Denmark

Heinz Läubli, MD, PhD
University Hospital Basel – Switzerland

Allison Betof Warner, MD, PhD
Stanford Cancer Center – United States

Clinical Cancer Immunotherapy Section

Section Editors

Jason J. Luke, MD, FACP
UPMC Hillman Cancer Center – United States

Douglas G. McNeel, MD, PhD
University of Wisconsin Carbone Cancer Center – United States

Associate Editors

Paulo Antonio Ascierto, MD
Istituto Nazional Tumori-Fondazione 'G.Pascale' – Italy

Tina Cascone, MD, PhD
The University of Texas MD Anderson Cancer Center – United States

Margaret E. Gatti-Mays, MD, MPH
Ohio State University Comprehensive Cancer Center – United States

Francois Ghiringhelli, PhD
Institut National De La Sante Et De Le Recherche Medicale (INSERM) – France

James J. Harding, MD
Memorial Sloan Kettering Cancer Center – United States

Douglas B. Johnson, MD, MSCI
Vanderbilt University Medical Center – United States

Yangqiu Li, MD
Jinan University School of Medicine China

Ravi A. Madan, MD
National Cancer Institute, National Institutes of Health United States

Luca Mazzarella, MD, PhD
European Institute of Oncology Italy

Kunle Odunsi, MD, PhD
University of Chicago Medicine Comprehensive Cancer Center – United States

Ravi Patel, MD, PhD
University of Pittsburgh United States

Commentary/Editorials Section

Section Editor

Christian Capitini, MD
University of Wisconsin, Madison – United States

Associate Editors

Ana Carrizosa Anderson, MD
Harvard University – United States

Diwakar Davar, MD
UPMC Hillman Cancer Center – United States

Michael Dougan, MD, PhD
Massachusetts General Hospital – United States

William J. Murphy, PhD
University of California, Davis – United States

Guidelines and Consensus Statements Section

Section Editor

Robert L. Ferris, MD, PhD
UNC Lineberger Comprehensive Cancer Center – United States

Immune Cell Therapies and Immune Cell Engineering Section

Section Editor

Aude Chapuis, MD
Fred Hutchinson Cancer Research Center – United States

Marcela V. Maus, MD, PhD
Massachusetts General Hospital – United States

Associate Editors

Marco L. Davila, MD, PhD
Roswell Park Comprehensive Cancer Center – United States

Joseph A. Fraietta, PhD
University of Pennsylvania – United States

Sara Ghorashian, MD, PhD
University College London – United Kingdom

Michael Hudecek, MD
Universitätsklinikum Würzburg – Germany

Michael D. Kalos, PhD
Next Pillar Consulting – United States

Gerald Linette, MD, PhD
University of Pennsylvania – United States

Daniel J. Powell Jr., PhD
University of Pennsylvania – United States

Marco Ruella, MD
University of Pennsylvania – United States

Lillian Seu, PhD
Revolution Medicines – United States

Nirali N. Shah, MD, MHSc
National Cancer Institute, National Institutes of Health – United States

Eric L. Smith, MD, PhD
Dana-Farber Cancer Institute – United States

Maria Themeli, MD, PhD
VUmc Cancer Center Amsterdam – Netherlands

Immunotherapy Biomarkers Section

Section Editors

Ignacio Melero, MD, PhD
Foundation for Applied Medical Research (FIMA) – Spain

Kurt A. Schalper, MD, PhD
Yale School of Medicine – United States

Alexandra Snyder Charen, MD
Generate Biomedicines – United States

Associate Editors

Maria Ascierto, PhD
University of Glasgow – United Kingdom

Carlo B. Bifulco, MD
Providence Portland Medical Center – United States

John C. Castle, PhD
Monte Rosa Therapeutics – Switzerland

Alessandra Cesano, MD, PhD
ESSA Pharma Inc. – United States

Carlos de Andrea, MD, PhD
University of Navarra– Spain

Eric Deutsch, MD, PhD
Gustave Roussy Cancer Campus – France

Elisabeth G.E. de Vries, MD, PhD
University Medical Centre Groningen – Netherlands

Jolanda de Vries, PhD
Radboud University Nijmegen – Netherlands

Rejean Lapointe, PhD
Universite De Montreal, University Hospital (CRCHUM) – Canada

Christian H. Ottensmeier, MD, PhD, FRCP
University of Southampton – United Kingdom

Graham P. Pawelec, PhD
University of Tuebingen – Germany

Licia Rivoltini, MD
Fondazione IRCCS Istituto Nazionale Tumori – Italy

Barbara Seliger, MD, PhD
Martin Luther University Halle-Wittenberg – Germany

Craig L. Slingluff Jr., MD
University of Virginia – United States

Claudio Tripodo, MD
University of Palermo – Italy

Jinada Yuan, MD, PhD
Merck & Co. – United States

Jon Zugazagoitia, MD, PhD
Hospital Gral 12 de Octubre – Spain

Oncolytic and Local Immunotherapy Section

Section Editor

Howard L. Kaufman, MD, FACS
Massachusetts General Hospital – United States

Associate Editors

Darrel J. Irvine, PhD
Massachusetts Institute of Technology – United States

Samuel Rabkin, PhD
Massachusetts General Hospital – United States

K. Dane Wittrup, PhD
Massachusetts Institute of Technology – United States

Dmitriy Zamarin, MD, PhD
Icahn School of Medicine at Mount Sinai – United States

Reviews Section

Section Editors

Sandra Demaria, MD
Weill Cornell Medical College – United States

Lawrence Fong, MD
Fred Hutchinson Cancer Center – United States

Associate Editors

Ira Mellman, PhD, FAACR, FAIO
Parker Institute for Cancer Immunotherapy, Medici Therapeutics – United States

James J. Mule, PhD
H. Lee Moffitt Cancer Center United States

Specialty Editors

Consulting Editor, Special Series and Reviews

Pedro J. Romero, MD
Novigenix – Switzerland

Consulting Editor

Thomas F. Gajewski, MD, PhD
University of Chicago – United States

Social Media Editors

Kristin G. Anderson, PhD
University of Virginia – United States

Praveen Bommareddy, PhD, MS
Replimune, Inc. – United States

Cheng Sun, MD, PhD
University of Science and Technology of China, Hefei – China